- Report
- April 2025
- 175 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- August 2024
- 150 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- December 2024
- 144 Pages
Global
From €13726EUR$14,995USD£11,666GBP
- Report
- November 2018
- 30 Pages
China
From €2014EUR$2,200USD£1,712GBP
- Report
- May 2024
- 128 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2023
- 160 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- October 2022
- 177 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 174 Pages
North America
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 181 Pages
Middle East, Africa
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 202 Pages
Europe
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- July 2022
- 255 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- April 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 85 Pages
North America
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 80 Pages
Europe
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 176 Pages
Global
From €4348EUR$4,750USD£3,695GBP

Novolog is a brand of insulin used to treat diabetes, a condition in which the body does not produce or properly use insulin. It is a fast-acting insulin that helps to control blood sugar levels. Novolog belongs to a class of drugs known as endocrine and metabolic disorders drugs, which are used to treat a variety of conditions related to hormones and metabolism. These drugs work by either increasing or decreasing the production of hormones or by altering the way the body uses them.
Novolog is used to treat both type 1 and type 2 diabetes. It is typically taken before meals to help control blood sugar levels. It can also be used in combination with other diabetes medications. Novolog is available in both injectable and inhalable forms.
The Novolog market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and AstraZeneca. Show Less Read more